Quebec Cannabis Monopoly Analysis: The Framework Says It's Still Losing

Quebec runs the only cannabis retail monopoly in this publication's Canadian coverage — SQDC is itself the sole legal retailer in the province, unlike Alberta's private licensing model. Quebec bans home cultivation entirely (one of only two provinces to do so), sets the country's highest legal purchase age at 21, and sold zero vape products until November 2025 despite roughly a quarter of Quebec cannabis consumers reporting past-year vape use. Applying this publication's standard framework — 18% participation, 1.0 g/day, the same methodology used across every U.S. state and Canadian province in this series — Quebec's legal retail channel captures roughly 32% of modeled demand. SQDC's own annual reports claim a considerably higher figure, sourced from a Quebec Ministry of Finance total-market estimate that has itself been revised several times as the government's own sales grew. The cleanest, least assumption-dependent comparison available: Alberta moves 2.15 times more cannabis per adult than Quebec does, using the same fiscal year and a consistent population basis for both — though, as this piece gets into, that gap reflects legal-channel throughput more clearly than it reflects any confidently known difference in underlying demand.

Market Overview

SQDC — Société québécoise du cannabis — is a Crown corporation and Quebec's only licensed non-medical cannabis retailer. There is no private competition; every legal sale in the province runs through SQDC's own stores or website. That's a fundamentally different structure from Alberta, where AGLC licenses and wholesales to independent private retailers who compete on price and selection.

Quebec's restrictions run deeper than the monopoly structure itself. The legal purchase age is 21, three years above Alberta's 18 and the highest in Canada. Home cultivation — legal federally, and permitted in Alberta at up to four plants per household — is banned outright in Quebec, one of only two provinces to do so. And SQDC did not sell any vape products through its entire history until November 2025; its own reporting shows Quebec consumers had access to tablets, tinctures, and a narrow edibles catalog, but nothing to compete with an entire product category that typically runs a quarter or more of cannabis sales elsewhere.

Current State

SQDC's most recent full fiscal year (ended March 28, 2026) recorded $809.5 million in sales, 165,169 kg sold, and $132.4 million in net income, through 110 stores. The first quarter of the current fiscal year (12 weeks ended June 20, 2026) shows continued growth: $197.3 million in sales, 39,936 kg sold, up 9.0% and 7.6% year over year respectively, with the store count reaching roughly 112. SQDC itself attributes the increase notably to six new stores, the vape rollout, and optimized opening hours — precisely the kinds of accessibility and product-offer changes expected to improve legal-channel capture, rather than evidence that underlying demand is expanding on its own.

For the fiscal year that lines up most closely with Alberta's most recent complete data (year ended March 29, 2025), SQDC sold 149,223 kg for $741.5 million — an average price of $5.71 per gram, tax included. That figure is a genuine retail number, unlike AGLC's $693.0 million, which is wholesale revenue collected from selling to licensed retailers rather than what Alberta consumers paid at the register. The two headline dollar figures in this comparison are not measuring the same thing, and shouldn't be read side by side without that distinction.

Total Addressable Market and Capture

Quebec's population is approximately 9.03 million, with roughly 21.6% under 21 (Quebec's own legal purchase age, three years above the country's usual 18-19). Netting that out yields roughly 7.08 million adults 21 and over. Applying this framework's standard 18% participation and 1.0 g/day — identical to what's used for every U.S. state and for Alberta — modeled annual demand comes to roughly 465,000 kg.

Against that baseline, SQDC's 149,223 kg works out to roughly 32% legal retail capture. That's a meaningfully lower number than SQDC's own annual reports claim: the corporation's cited capture rate climbed from 53% (fiscal 2020-21) to 62.8% (fiscal 2023-24), sourced from a Quebec Ministry of Finance total-market estimate that has itself moved several times as the underlying figure was revised — from roughly 150 tonnes to 173, then 187, then close to 190 across different reporting years. That number is modeled, not observed: SQDC's sales are audited; the total-market denominator it's divided by is a survey-derived estimate, produced by the same government whose retail monopoly is being measured against it. Official provenance doesn't make a modeled denominator more accurate than this framework's own — it's simply a different set of assumptions, applied inconsistently across jurisdictions rather than uniformly the way this publication's methodology is.

Quebec's homegrow ban matters here in a way it didn't for Alberta. In the Alberta analysis, legal cultivation and a separate federal medical channel — both entirely outside AGLC's wholesale reporting — closed a meaningful share of the apparent gap between modeled demand and AGLC's own volume. Quebec residents can still access the federal medical channel, and Quebec's own 2025 survey found 15% of consumers reported obtaining cannabis legally by traveling to another province and 38% received cannabis from friends or family — real, non-SQDC, not-necessarily-illicit sourcing, though these are consumer-incidence figures, not volume shares, so they can't be plugged directly into the kilogram math. Allowing a modest share for the medical channel alone (this analysis puts it at roughly 3.5% of modeled demand, in the absence of a legal homegrow channel to add to it) still leaves a large unaccounted residual — this framework's math implies something in the mid-60s percent range once medical is netted out, well above SQDC's own claimed illicit share in the high 30s to low 40s. That residual almost certainly isn't all illicit-market demand; some of it is legal purchases in other provinces, gifting, and sourcing this analysis can't size precisely from public data. But it's a genuinely large gap regardless of how it's split, and considerably larger than SQDC's own number suggests.

Alberta, Side by Side

The most defensible comparison in this piece doesn't depend on either province's total-market estimate at all. Using the same fiscal year (ended in Q1 2025) and each province's own age-adjusted adult population — Alberta's 4.03 million adults 18-plus against Quebec's 7.08 million adults 21-plus — Alberta moved 45.3 kg per 1,000 adults; Quebec moved 21.1 kg per 1,000 adults. Alberta's private, competitive retail model distributed 2.15 times more cannabis per adult than Quebec's monopoly, using each province's reported dried-cannabis-equivalent volume and legal-age population, without relying on a modeled total-market estimate. One caveat worth stating plainly: these aren't literal grams of flower. Both provinces convert product mix into dried-cannabis equivalents using Health Canada's own methodology, and the two provinces' product mixes are radically different — Alberta's vapes and extracts alone were 39.6% of wholesale dollars in fiscal 2024-25, while Quebec sold no vapes at all until November 2025. A concentrate-heavy province gets more exposure to that conversion methodology, which means the 2.15x figure is a real measure of legal-channel throughput, but not a perfectly neutral physical-mass comparison.

Federal and provincial surveys consistently report lower cannabis prevalence and frequency in Quebec than in Alberta, but those self-reported differences shouldn't be read as directly explaining the 2.15x gap. Canadian prevalence surveys disagree substantially even at the national level — recent estimates from different surveys have ranged from 21% to 32% for what should be roughly the same measure — and Quebec's own statistical agency acknowledges it doesn't know how much cannabis use in the province goes underreported. Statistics Canada's wastewater testing program, one of the only non-survey-based measures available, found Montreal's cannabis metabolite levels roughly 3.4 times higher than Edmonton's in its first pilot period (2018-19), then found Edmonton running meaningfully higher than Montreal within about two years — a reversal that undercuts treating any single survey-based prevalence gap as settled fact. Statistics Canada itself has also attributed part of Quebec's exceptionally low legal sales specifically to its product restrictions — no vaping, no topicals until recently, a limited edibles catalog — rather than treating the low number as purely a demand story. The 2.15-to-1 legal-volume gap is real and well-documented. What it reflects — some genuine difference in Quebec cannabis consumption, some structural product-access gap, or some mix of both — isn't something this analysis, or the underlying survey data, can currently resolve with confidence.

The Bottom Line

Quebec's monopoly model is growing — sales, volume, and store count are all up, and SQDC itself credits the vape rollout, new stores, and optimized hours for the latest quarter's gains. But growth off a low base is still a low base. This framework, applied with the same assumptions used everywhere else in this series, puts Quebec's legal capture at roughly 32%, well below what SQDC's own government-sourced figure claims, and a large residual remains unaccounted for even after allowing for the federal medical channel and other legal, non-SQDC sourcing Quebec residents can access. Set against Alberta's private model moving more than double the cannabis per adult over the same period, the comparison is stark — though how much of that gap is Quebec's monopoly underperforming versus a genuine difference in underlying demand isn't something the available survey data can resolve with confidence. What is clear: a government retail monopoly with a higher purchase age, no legal homegrow, and a product catalog missing an entire major category until months ago has real, identifiable reasons to underperform a competitive private market next door — reasons Statistics Canada itself has pointed to directly.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.